Company / EPS (Diluted)
Penumbra, Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$2.32
FY2025
5-year range
-$0.44 / $2.32
FY2021-FY2025
Trend
+4740.0%
vs FY2024
Sector context
#52 of 159
Health Care
What the data says
EPS (Diluted) changed +4740% YoY in FY2025, a notable deviation from the 9-year average annual change of +646%.
Based on SEC 10-K filings.
2.32 in FY2025 with a 5-year CAGR of +66.7%.
Improved from $0.14 to $2.32 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +66.7%
- 10-Year CAGR
- -
Sector benchmark
#52 of 159 in Health CareTop 33% of 159This company $2.32 Sector average $1.67
▼
+39.1% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 4740.0% year-over-year.
- Ranks #52 out of 159 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.11 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.32 | +4740.0% |
| FY2024 | -$0.05 | -135.7% |
| FY2023 | $0.14 | +131.8% |
| FY2022 | -$0.44 | -132.8% |
| FY2021 | $1.34 | +644.4% |
| FY2020 | $0.18 | +38.5% |
| FY2019 | $0.13 | -70.5% |
| FY2018 | $0.44 | +450.0% |
| FY2017 | $0.08 | +144.4% |
| FY2016 | -$0.18 | -228.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026